mvjrМедицинский вестник Юга РоссииMedical Herald of the South of Russia2219-80752618-7876The Rostov State Medical University10.21886/2219-8075-2022-13-1-13-23mvjr-1481Research ArticleЭНДОКРИНОЛОГИЯENDOCRYNOLOGYПерспективные разработки в области дифференциальной диагностики доброкачественных и злокачественных узлов щитовидной железыPromising developments in the fi eld of diff erential diagnosis of benign and malignant thyroid noduleshttps://orcid.org/0000-0002-9574-105XВорохобинаН. В.VorokhobinaN. V.

Наталья Владимировна Ворохобина - доктор медицинских наук, проф., заведующая кафедрой эндокринологии им. акад. В.Г. Баранова, SPIN-code: 4062-6409.

Санкт-Петербург

Natalya V. Vorokhobina - Dr. Sci (Med.), Professor, Head of the V.G. Baranov Department of Endocrinology.

St. Petersburg

natalya.vorokhobina@szgmu.ruhttps://orcid.org/0000-0001-7826-7184БарановВ. Л.BaranovV. L.

Баранов Виталий Леонидович - доктор медицинских наук, профессор кафедры эндокринологии им. акад. В.Г. Баранова.

Санкт-Петербург

Vitalii L. Baranov - Dr. Sci (Med.), Professor, Head of the V.G. Baranov Department of Endocrinology.

St. Petersburg

Vitalii.Baranov@szgmu.ruhttps://orcid.org/0000-0001-8734-2449ФогтС. Н.FogtS. N.

Фогт Сергей Николаевич - кандидат медицинских наук, доцент кафедры эндокринологии им. акад. В.Г. Баранова.

Санкт-Петербург

Sergei N. Fogt - Cand. Sci (Med.), Associate Professor. the V.G. Baranov Department of Endocrinology.

St. Petersburg

s_fogt@mail.ruhttps://orcid.org/0000-0003-4990-5946КузнецоваА. В.KuznetsovaF. V.

Кузнецова Алла Васильевна - кандидат медицинских наук, доцент кафедры эндокринологии имени акад. В.Г. Баранова.

Санкт-Петербург

Alla V. Kuznetcova - Cand. Sci (Med.), Associate Professor. the V.G. Baranov Department of Endocrinology.

St. Petersburg

Alla.Kuznetcova@szgmu.ruhttps://orcid.org/0000-0002-1977-8299БаландинаК. А.BalandinaK. A.

Баландина Ксения Александровна - кандидат медицинских наук, доцент кафедры эндокринологии имени акад. В.Г. Баранова.

Санкт-Петербург

Kseniya A. Balandina - Cand. Sci (Med.), Associate Professor. the V.G. Baranov Department of Endocrinology.

St. Petersburg

ksenya_sautina@mail.ruhttps://orcid.org/0000-0003-3599-3199ГалаховаР. К.GalakhovaR. K.

Галахова Равиля Камильевна - кандидат медицинских наук, доцент кафедры эндокринологии имени акад. В.Г. Баранова.

Санкт-Петербург

Ravilya K. Galakhova - Cand. Sci (Med.),  Associate Professor. the V.G. Baranov Department of Endocrinology.

St. Petersburg

rgalakhova@gmail.comСеверо-Западный государственный медицинский Университет им. И.И. МечниковаРоссияI.I. Mechnikov North-Western State Medical UniversityRussian Federation2022300320221311323Copyright © Ворохобина Н.В., Баранов В.Л., Фогт С.Н., Кузнецова А.В., Баландина К.А., Галахова Р.К., 20222022Ворохобина Н.В., Баранов В.Л., Фогт С.Н., Кузнецова А.В., Баландина К.А., Галахова Р.К.Vorokhobina N.V., Baranov V.L., Fogt S.N., Kuznetsova F.V., Balandina K.A., Galakhova R.K.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.medicalherald.ru/jour/article/view/1481

В последние годы возможности определения природы узлов щитовидной железы были существенно улучшены посредством усовершенствования традиционных методов, таких как ультразвуковое исследование (УЗИ) и тонкоигольная аспирационная биопсия (ТАБ), а также путём создания принципиально новых подходов. В обзоре приведены наиболее актуальные достижения последних лет. Поиск литературы проведён в библиографической базе Российского индекса научного цитирования по словам «узел», «щитовидная железа», «диагностика», «рак» на сайте «https://www.elibrary.ru», а также в базе данных медицинских и биологических публикаций Национального центра биотехнологической информации США по словам «nodule», «thyroid», «diagnostics», «cancer» на сайте «https://pubmed.ncbi. nlm.nih.gov». Проведён анализ источников за последние 5 лет.

In recent years, the ability to determine the nature of thyroid nodules has been signifi cantly improved both through the improvement of traditional methods, such as ultrasound examination (ultrasound) and fi ne needle aspiration biopsy (TAB), and through the creation of fundamentally new approaches. Th e review contains the most relevant achievements of recent years. Th e literature search was carried out in the bibliographic base of the Russian Science Citation Index for the words «node», «thyroid gland», «diagnosis», «cancer» on the site «https://www.elibrary.ru», as well as in the database of medical and Biological publications of the US National Center for Biotechnology Information on «nodule», «thyroid», «diagnostics», «cancer» at https://pubmed.ncbi.nlm.nih.gov. Th e analysis of sources for the last 5 years has been carried out.

обзорузелщитовидная железадиагностикаракreviewnodulethyroid glanddiagnosticscancerTh e study did not have sponsorshipReferencesLim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in Th yroid Cancer Incidence and Mortality in the United States, 1974-2013. JAMA. 2017;317(13):1338-1348. DOI: 10.1001/jama.2017.2719Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in Th yroid Cancer Incidence and Mortality in the United States, 1974-2013. JAMA. 2017;317(13):1338-1348. DOI: 10.1001/ jama.2017.2719Jegerlehner S, Bulliard JL, Aujesky D, Rodondi N, Germann S, et al. Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study. PLoS One. 2017;12(6):e0179387. DOI: 10.1371/journal.pone.0179387Jegerlehner S, Bulliard JL, Aujesky D, Rodondi N, Germann S, et al. Overdiagnosis and overtreatment of thyroid cancer: A populationbased temporal trend study. PLoS One. 2017;12(6):e0179387. DOI: 10.1371/journal.pone.0179387Xu L, Gao J, Wang Q, Yin J, Yu P, et al. Computer-Aided Diagnosis Systems in Diagnosing Malignant Th yroid Nodules on Ultrasonography: A Systematic Review and Meta-Analysis. Eur Th yroid J. 2020;9(4):186-193. DOI: 10.1159/000504390Xu L, Gao J, Wang Q, Yin J, Yu P, et al. Computer-Aided Diagnosis Systems in Diagnosing Malignant Th yroid Nodules on Ultrasonography: A Systematic Review and Meta-Analysis. Eur Th yroid J. 2020;9(4):186-193. DOI: 10.1159/000504390Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, et al. 2015 American Th yroid Association Management Guidelines for Adult Patients with Th yroid Nodules and Diff erentiated Th yroid Cancer: Th e American Th yroid Association Guidelines Task Force on Th yroid Nodules and Diff erentiated Th yroid Cancer. Th yroid. 2016;26(1):1-133. DOI: 10.1089/thy.2015.0020Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, et al. 2015 American Th yroid Association Management Guidelines for Adult Patients with Th yroid Nodules and Diff erentiated Th yroid Cancer: Th e American Th yroid Association Guidelines Task Force on Th yroid Nodules and Diff erentiated Th yroid Cancer. Th yroid. 2016;26(1):1-133. DOI: 10.1089/thy.2015.00205. Remonti LR, Kramer CK, Leitão CB, Pinto LC, Gross JL. Th yroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies. Th yroid. 2015;25(5):538-50. DOI: 10.1089/thy.2014.0353Remonti LR, Kramer CK, Leitão CB, Pinto LC, Gross JL. Th yroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies. Th yroid. 2015;25(5):53850. DOI: 10.1089/thy.2014.0353Remonti LR, Kramer CK, Leitão CB, Pinto LC, Gross JL. Th yroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies. Th yroid. 2015;25(5):53850. DOI: 10.1089/thy.2014.0353Li X, Zhang S, Zhang Q, Wei X, Pan Y, et al. Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study. Lancet Oncol. 2019;20(2):193–201. DOI: 10.1016/s1470-2045(18)30762-9Li X, Zhang S, Zhang Q, Wei X, Pan Y, et al. Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study. Lancet Oncol. 2019;20(2):193– 201. DOI: 10.1016/s1470-2045(18)30762-9Yu J, Deng Y, Liu T, Zhou J, Jia X, et al. Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics. Nat Commun. 2020;11(1):4807. DOI: 10.1038/s41467-020-18497-3Li X, Zhang S, Zhang Q, Wei X, Pan Y, et al. Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study. Lancet Oncol. 2019;20(2):193–201. DOI: 10.1016/s1470-2045(18)30762-9Hu C, Feng Y, Huang P, Jin J. Adverse reactions aft er the use of SonoVue contrast agent: Characteristics and nursing care experience. Medicine (Baltimore). 2019;98(44):e17745. DOI: 10.1097/MD.0000000000017745Yu J, Deng Y, Liu T, Zhou J, Jia X, et al. Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics. Nat Commun. 2020;11(1):4807. DOI: 10.1038/s41467-020-18497-3Sidhu PS, Cantisani V, Dietrich CF, Gilja OH, Saft oiu A, et al. Th e EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in NonHepatic Applications: Update 2017 (Long Version). Ultraschall Med. 2018;39(2):e2-e44. DOI: 10.1055/a-0586-1107Yu J, Deng Y, Liu T, Zhou J, Jia X, et al. Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics. Nat Commun. 2020;11(1):4807. DOI: 10.1038/s41467-020-18497-3Zhang J, Zhang X, Meng Y, Chen Y. Contrast-enhanced ultrasound for the diff erential diagnosis of thyroid nodules: An updated meta-analysis with comprehensive heterogeneity analysis. PLoS One. 2020;15(4):e0231775. DOI: 10.1371/journal.pone.0231775Hu C, Feng Y, Huang P, Jin J. Adverse reactions aft er the use of SonoVue contrast agent: Characteristics and nursing care experience. Medicine (Baltimore). 2019;98(44):e17745. DOI: 10.1097/MD.0000000000017745Zhang Y, Zhou P, Tian SM, Zhao YF, Li JL, Li L. Usefulness of combined use of contrast-enhanced ultrasound and TI-RADS classifi cation for the diff erentiation of benign from malignant lesions of thyroid nodules. Eur Radiol. 2017;27(4):1527-1536. DOI: 10.1007/s00330-016-4508-yHu C, Feng Y, Huang P, Jin J. Adverse reactions aft er the use of SonoVue contrast agent: Characteristics and nursing care experience. Medicine (Baltimore). 2019;98(44):e17745. DOI: 10.1097/MD.0000000000017745Qiu Y, Xing Z, Liu J, Peng Y, Zhu J, Su A. Diagnostic reliability of elastography in thyroid nodules reported as indeterminate at prior fi ne-needle aspiration cytology (FNAC): a systematic review and Bayesian meta-analysis. Eur Radiol. 2020;30(12):6624-6634. DOI: 10.1007/s00330-020-07023-0Sidhu PS, Cantisani V, Dietrich CF, Gilja OH, Saft oiu A, et al. Th e EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version). Ultraschall Med. 2018;39(2):e2-e44. DOI: 10.1055/a-0586-1107Тимофеева Л.А., Сенча А.Н., Тухбатуллин М.Г., Шубин Л.Б. Современные аспекты ультразвуковой эластографии в дифференциальной диагностике узловых новообразований щитовидной железы. Российский электронный журнал лучевой диагностики. 2019;9(3):30–40. DOI:10.21569/2222-7415-2019-9-3-30-40Zhang J, Zhang X, Meng Y, Chen Y. Contrast-enhanced ultrasound for the diff erential diagnosis of thyroid nodules: An updated metaanalysis with comprehensive heterogeneity analysis. PLoS One. 2020;15(4):e0231775. DOI: 10.1371/journal.pone.0231775Cosgrove D, Piscaglia F, Bamber J, Bojunga J, Correas JM, et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications. Ultraschall Med. 2013;34(3):238-53. DOI: 10.1055/s-0033-1335375Zhang Y, Zhou P, Tian SM, Zhao YF, Li JL, Li L. Usefulness of combined use of contrast-enhanced ultrasound and TI-RADS classifi cation for the diff erentiation of benign from malignant lesions of thyroid nodules. Eur Radiol. 2017;27(4):1527-1536. DOI: 10.1007/s00330-016-4508-yYoon SJ, Na DG, Gwon HY, Paik W, Kim WJ, et al. Similarities and Diff erences Between Th yroid Imaging Reporting and Data Systems. AJR Am J Roentgenol. 2019;213(2):W76-W84. DOI: 10.2214/AJR.18.20510Qiu Y, Xing Z, Liu J, Peng Y, Zhu J, Su A. Diagnostic reliability of elastography in thyroid nodules reported as indeterminate at prior fi ne-needle aspiration cytology (FNAC): a systematic review and Bayesian meta-analysis. Eur Radiol. 2020;30(12):6624-6634. DOI: 10.1007/s00330-020-07023-0Ha EJ, Na DG, Baek JH, Sung JY, Kim JH, Kang SY. US Fine-Needle Aspiration Biopsy for Th yroid Malignancy: Diagnostic Performance of Seven Society Guidelines Applied to 2000 Th yroid Nodules. Radiology. 2018;287(3):893-900. DOI: 10.1148/radiol.2018171074Timofeeva L.A., Sencha A.N., Tukhbatullin M.G., Shubin L.B. Modern aspects of ultrasound elastography in diff erential diagnosis of nodular thyroid neoplasms. REJR. 2019;9(3):30-40. (In Russ.). DOI: 10.21569/2222-7415-2019-9-3-30-40Ha EJ, Na DG, Moon WJ, Lee YH, Choi N. Diagnostic Performance of Ultrasound-Based Risk-Stratifi cation Systems for Th yroid Nodules: Comparison of the 2015 American Th yroid Association Guidelines with the 2016 Korean Th yroid Association/Korean Society of Th yroid Radiology and 2017 American College of Radiology Guidelines. Th yroid. 2018;28(11):1532-1537. DOI: 10.1089/thy.2018.0094. Erratum in: Th yroid. 2019;29(1):159. Title and abstract corrected. PMID: 30311862.Cosgrove D, Piscaglia F, Bamber J, Bojunga J, Correas JM, et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications. Ultraschall Med. 2013;34(3):238-53. DOI: 10.1055/s-0033-1335375Сердюкова О.С., Титов С.Е., Малахина Е.С., Рымар О.Д. МикроРНК – перспективные молекулярные маркеры обнаружения рака в узлах щитовидной железы. Клиническая и экспериментальная тиреоидология. 2018;14(3):140-148. DOI: 10.14341/ket9774Yoon SJ, Na DG, Gwon HY, Paik W, Kim WJ, et al. Similarities and Diff erences Between Th yroid Imaging Reporting and Data Systems. AJR Am J Roentgenol. 2019;213(2):W76-W84. DOI: 10.2214/AJR.18.20510Livhits MJ, Zhu CY, Kuo EJ, Nguyen DT, Kim J, et al. Eff ectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Th yroid Nodules: A Randomized Clinical Trial. JAMA Oncol. 2021;7(1):70-77. DOI: 10.1001/jamaoncol.2020.5935Ha EJ, Na DG, Baek JH, Sung JY, Kim JH, Kang SY. US FineNeedle Aspiration Biopsy for Th yroid Malignancy: Diagnostic Performance of Seven Society Guidelines Applied to 2000 Th yroid Nodules. Radiology. 2018;287(3):893-900. DOI: 10.1148/radiol.2018171074García Pascual L, Surralles ML, Morlius X, Garcia Cano L, González Mínguez C. Prevalence and associated malignancy of Bethesda category III cytologies of thyroid nodules assigned to the "cytological atypia" or "architectural atypia" groups. Endocrinol Diabetes Nutr (Engl Ed). 2018;65(10):577-583. (In English, Spanish). DOI: 10.1016/j.endinu.2018.07.001Ha EJ, Na DG, Moon WJ, Lee YH, Choi N. Diagnostic Performance of Ultrasound-Based Risk-Stratifi cation Systems for Th yroid Nodules: Comparison of the 2015 American Th yroid Association Guidelines with the 2016 Korean Th yroid Association/Korean Society of Th yroid Radiology and 2017 American College of Radiology Guidelines. Th yroid. 2018;28(11):1532-1537. DOI: 10.1089/thy.2018.0094. Erratum in: Th yroid. 2019;29(1):159. Title and abstract corrected. PMID: 30311862.Alshaikh S, Harb Z, Aljufairi E, Almahari SA. Classifi cation of thyroid fi ne-needle aspiration cytology into Bethesda categories: An institutional experience and review of the literature. Cytojournal. 2018;15:4. DOI: 10.4103/cytojournal.cytojournal_32_17Serdyukova O.S., Titov S.E., Malakhina E.S., Rymar O.D. MicroRNAs – promising molecular markers for detecting cancer in thyroid nodules. Clinical and experimental thyroidology. 2018;14(3):140-148. (In Russ.) DOI: 10.14341/ket9774Борсуков А.В., Тагиль А.О. Использование вакуумной тонкоигольной аспирационной биопсии у пациентов с многоузловым зобом. Таврический медико-биологический вестник. 2021;24(2):18–22. eLIBRARY ID: 46632677Livhits MJ, Zhu CY, Kuo EJ, Nguyen DT, Kim J, et al. Eff ectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Th yroid Nodules: A Randomized Clinical Trial. JAMA Oncol. 2021;7(1):70-77. DOI: 10.1001/jamaoncol.2020.5935Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367(8):70515. DOI: 10.1056/NEJMoa1203208García Pascual L, Surralles ML, Morlius X, Garcia Cano L, González Mínguez C. Prevalence and associated malignancy of Bethesda category III cytologies of thyroid nodules assigned to the "cytological atypia" or "architectural atypia" groups. Endocrinol Diabetes Nutr (Engl Ed). 2018;65(10):577-583. (In English, Spanish). DOI: 10.1016/j.endinu.2018.07.001Steward DL, Carty SE, Sippel RS, Yang SP, Sosa JA, et al. Performance of a Multigene Genomic Classifi er in Th yroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study. JAMA Oncol. 2019;5(2):204212. DOI: 10.1001/jamaoncol.2018.4616. Erratum in: JAMA Oncol. 2019;5(2):271. PMID: 30419129; PMCID: PMC6439562.Alshaikh S, Harb Z, Aljufairi E, Almahari SA. Classifi cation of thyroid fi ne-needle aspiration cytology into Bethesda categories: An institutional experience and review of the literature. Cytojournal. 2018;15:4. DOI: 10.4103/cytojournal.cytojournal_32_17Santos MTD, Buzolin AL, Gama RR, Silva ECAD, Dufl oth RM, et al. Molecular Classifi cation of Th yroid Nodules with Indeterminate Cytology: Development and Validation of a Highly Sensitive and Specifi c New miRNA-Based Classifi er Test Using Fine-Needle Aspiration Smear Slides. Th yroid. 2018;28(12):1618-1626. DOI: 10.1089/thy.2018.0254.Borsukov A.V., Tagil A.O. Use of vacuum fi ne-needle aspiration biopsy in patients with multinodular goiter. Tavricheskiy MedikoBiologicheskiy Vestnik. 2021;24(2):18–22. (In Russ.). eLIBRARY ID: 46632677Mazeh H, Deutch T, Karas A, Bogardus KA, Mizrahi I, et al. Next-Generation Sequencing Identifi es a Highly Accurate miRNA Panel Th at Distinguishes Well-Diff erentiated Th yroid Cancer from Benign Th yroid Nodules. Cancer Epidemiol Biomarkers Prev. 2018;27(8):858-863. DOI: 10.1158/1055-9965.EPI-18-0055Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367(8):705-15. DOI: 10.1056/NEJMoa1203208Лукьянов С.А., Сергийко С.В., Титов С.Е., Веряскина Ю.А., Мудунов А.М., и др. Новые возможности дооперационной диагностики анапластического рака щитовидной железы. Опухоли головы и шеи. 2021;11(1):34– 40. DOI: 10.17650/2222-1468-2021-11-1-34-40Steward DL, Carty SE, Sippel RS, Yang SP, Sosa JA, et al. Performance of a Multigene Genomic Classifi er in Th yroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study. JAMA Oncol. 2019;5(2):204-212. DOI: 10.1001/ jamaoncol.2018.4616. Erratum in: JAMA Oncol. 2019;5(2):271. PMID: 30419129; PMCID: PMC6439562.Wolinski K, Stangierski A, Ruchala M. Comparison of diagnostic yield of core-needle and fi ne-needle aspiration biopsies of thyroid lesions: Systematic review and metaanalysis. Eur Radiol. 2017;27(1):431-436. DOI: 10.1007/s00330-016-4356-9Santos MTD, Buzolin AL, Gama RR, Silva ECAD, Dufl oth RM, et al. Molecular Classifi cation of Th yroid Nodules with Indeterminate Cytology: Development and Validation of a Highly Sensitive and Specifi c New miRNA-Based Classifi er Test Using Fine-Needle Aspiration Smear Slides. Th yroid. 2018;28(12):1618-1626. DOI: 10.1089/thy.2018.0254.Ha EJ, Suh CH, Baek JH. Complications following ultrasoundguided core needle biopsy of thyroid nodules: a systematic review and meta-analysis. Eur Radiol. 2018;28(9):38483860. DOI: 10.1007/s00330-018-5367-5Mazeh H, Deutch T, Karas A, Bogardus KA, Mizrahi I, et al. NextGeneration Sequencing Identifi es a Highly Accurate miRNA Panel Th at Distinguishes Well-Diff erentiated Th yroid Cancer from Benign Th yroid Nodules. Cancer Epidemiol Biomarkers Prev. 2018;27(8):858-863. DOI: 10.1158/1055-9965.EPI-18-0055Shin I, Kim EK, Moon HJ, Yoon JH, Park VY, et al. CoreNeedle Biopsy Does Not Show Superior Diagnostic Performance to Fine-Needle Aspiration for Diagnosing Th yroid Nodules. Yonsei Med J. 2020;61(2):161-168. DOI: 10.3349/ymj.2020.61.2.161Lukyanov S.A., Sergiyko S.V., Titov S.E., Veryaskina Yu.A., Mudunov A.M., et al. New opportunities for preoperative diagnosis of anaplastic thyroid cancer. Head and Neck Tumors (HNT). 2021;11(1):34-40. (In Russ.) DOI: 10.17650/2222-1468-2021-11-1-34-40Soumya, Whitehorn A, Ooi EH, Lockwood C. Accuracy of core needle biopsy compared to fi ne needle biopsy for the diagnosis of neoplasm in patients with suspected head and neck cancers: a systematic review protocol of diagnostic test accuracy. JBI Evid Synth. 2020;18(7):1602-1608. DOI: 10.11124/JBISRIR-D-19-00225Wolinski K, Stangierski A, Ruchala M. Comparison of diagnostic yield of core-needle and fi ne-needle aspiration biopsies of thyroid lesions: Systematic review and meta-analysis. Eur Radiol. 2017;27(1):431-436. DOI: 10.1007/s00330-016-4356-9Lan L, Luo Y, Zhou M, Huo L, Chen H, et al. Comparison of Diagnostic Accuracy of Th yroid Cancer With UltrasoundGuided Fine-Needle Aspiration and Core-Needle Biopsy: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2020;11:44. DOI: 10.3389/fendo.2020.00044Ha EJ, Suh CH, Baek JH. Complications following ultrasoundguided core needle biopsy of thyroid nodules: a systematic review and meta-analysis. Eur Radiol. 2018;28(9):3848-3860. DOI: 10.1007/s00330-018-5367-5Zhang A, Wang C, Lu H, Chen X, Ba Y, et al. Altered Serum MicroRNA Profi le May Serve as an Auxiliary Tool for Discriminating Aggressive Th yroid Carcinoma from Nonaggressive Th yroid Cancer and Benign Th yroid Nodules. Dis Markers. 2019;2019:3717683. DOI: 10.1155/2019/3717683Shin I, Kim EK, Moon HJ, Yoon JH, Park VY, et al. Core-Needle Biopsy Does Not Show Superior Diagnostic Performance to FineNeedle Aspiration for Diagnosing Th yroid Nodules. Yonsei Med J. 2020;61(2):161-168. DOI: 10.3349/ymj.2020.61.2.161Rosignolo F, Sponziello M, Giacomelli L, Russo D, Pecce V, et al. Identifi cation of Th yroid-Associated Serum microRNA Profi les and Th eir Potential Use in Th yroid Cancer FollowUp. J Endocr Soc. 2017;1(1):3-13. DOI: 10.1210/js.2016-1032Soumya, Whitehorn A, Ooi EH, Lockwood C. Accuracy of core needle biopsy compared to fi ne needle biopsy for the diagnosis of neoplasm in patients with suspected head and neck cancers: a systematic review protocol of diagnostic test accuracy. JBI Evid Synth. 2020;18(7):1602-1608. DOI: 10.11124/JBISRIR-D-19-00225Kondrotienė A, Daukša A, Pamedytytė D, Kazokaitė M, Žvirblienė A, et al. Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Th yroid Cancer. Int J Mol Sci. 2020;21(17):6445. DOI: 10.3390/ijms21176445Lan L, Luo Y, Zhou M, Huo L, Chen H, et al. Comparison of Diagnostic Accuracy of Th yroid Cancer With Ultrasound-Guided Fine-Needle Aspiration and Core-Needle Biopsy: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2020;11:44. DOI: 10.3389/fendo.2020.00044Toraih EA, Elshazli RM, Trinh LN, Hussein MH, Attia AA, et al. Diagnostic and Prognostic Performance of Liquid Biopsy-Derived Exosomal MicroRNAs in Th yroid Cancer Patients: A Systematic Review and Meta-Analysis. Cancers (Basel). 2021;13(17):4295. DOI: 10.3390/cancers13174295Zhang A, Wang C, Lu H, Chen X, Ba Y, et al. Altered Serum MicroRNA Profi le May Serve as an Auxiliary Tool for Discriminating Aggressive Th yroid Carcinoma from Nonaggressive Th yroid Cancer and Benign Th yroid Nodules. Dis Markers. 2019;2019:3717683. DOI: 10.1155/2019/3717683Wijewardene AA, Chehade M, Gild ML, Clift on-Bligh RJ, Bullock M. Translational Utility of Liquid Biopsies in Th yroid Cancer Management. Cancers (Basel). 2021;13(14):3443. DOI: 10.3390/cancers13143443Rosignolo F, Sponziello M, Giacomelli L, Russo D, Pecce V, et al. Identifi cation of Th yroid-Associated Serum microRNA Profi les and Th eir Potential Use in Th yroid Cancer Follow-Up. J Endocr Soc. 2017;1(1):3-13. DOI: 10.1210/js.2016-1032Li X, Jiang W, Zhong Y, Wu L, Sun G, et al. Advances of circular RNAs in thyroid cancer: An overview. Biomed Pharmacother. 2021;140:111706. DOI: 10.1016/j.biopha.2021.111706Kondrotienė A, Daukša A, Pamedytytė D, Kazokaitė M, Žvirblienė A, et al. Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Th yroid Cancer. Int J Mol Sci. 2020;21(17):6445. DOI: 10.3390/ijms21176445Shi E, Ye J, Zhang R, Ye S, Zhang S, et al. A Combination of circRNAs as a Diagnostic Tool for Discrimination of Papillary Th yroid Cancer. Onco Targets Th er. 2020;13:43654372. DOI: 10.2147/OTT.S247796Toraih EA, Elshazli RM, Trinh LN, Hussein MH, Attia AA, et al. Diagnostic and Prognostic Performance of Liquid Biopsy-Derived Exosomal MicroRNAs in Th yroid Cancer Patients: A Systematic Review and Meta-Analysis. Cancers (Basel). 2021;13(17):4295. DOI: 10.3390/cancers13174295Fan CM, Wang JP, Tang YY, Zhao J, He SY, et al. circMAN1A2 could serve as a novel serum biomarker for malignant tumors. Cancer Sci. 2019;110(7):2180-2188. DOI: 10.1111/cas.14034Wijewardene AA, Chehade M, Gild ML, Clift on-Bligh RJ, Bullock M. Translational Utility of Liquid Biopsies in Th yroid Cancer Management. Cancers (Basel). 2021;13(14):3443. DOI: 10.3390/cancers13143443Liu J, Zheng X, Liu H. Hsa_circ_0102272 serves as a prognostic biomarker and regulates proliferation, migration and apoptosis in thyroid cancer. J Gene Med. 2020;22(9):e3209. DOI: 10.1002/jgm.3209Li X, Jiang W, Zhong Y, Wu L, Sun G, et al. Advances of circular RNAs in thyroid cancer: An overview. Biomed Pharmacother. 2021;140:111706. DOI: 10.1016/j.biopha.2021.111706Sun JW, Qiu S, Yang JY, Chen X, Li HX. Hsa_circ_0124055 and hsa_circ_0101622 regulate proliferation and apoptosis in thyroid cancer and serve as prognostic and diagnostic indicators. Eur Rev Med Pharmacol Sci. 2020;24(8):43484360. DOI: 10.26355/eurrev_202004_21016Shi E, Ye J, Zhang R, Ye S, Zhang S, et al. A Combination of circRNAs as a Diagnostic Tool for Discrimination of Papillary Th yroid Cancer. Onco Targets Th er. 2020;13:4365-4372. DOI: 10.2147/OTT.S247796Lan X, Cao J, Xu J, Chen C, Zheng C, et al. Decreased expression of hsa_circ_0137287 predicts aggressive clinicopathologic characteristics in papillary thyroid carcinoma. J Clin Lab Anal. 2018;32(8):e22573. DOI: 10.1002/jcla.22573Fan CM, Wang JP, Tang YY, Zhao J, He SY, et al. circMAN1A2 could serve as a novel serum biomarker for malignant tumors. Cancer Sci. 2019;110(7):2180-2188. DOI: 10.1111/cas.14034Wu G, Zhou W, Pan X, Sun Z, Sun Y, et al. Circular RNA Profi ling Reveals Exosomal circ_0006156 as a Novel Biomarker in Papillary Th yroid Cancer. Mol Th er Nucleic Acids. 2020;19:1134-1144. DOI: 10.1016/j.omtn.2019.12.025Liu J, Zheng X, Liu H. Hsa_circ_0102272 serves as a prognostic biomarker and regulates proliferation, migration and apoptosis in thyroid cancer. J Gene Med. 2020;22(9):e3209. DOI: 10.1002/jgm.3209Salvianti F, Giuliani C, Petrone L, Mancini I, Vezzosi V, et al. Integrity and Quantity of Total Cell-Free DNA in the Diagnosis of Th yroid Cancer: Correlation with Cytological Classifi cation. Int J Mol Sci. 2017;18(7):1350. DOI: 10.3390/ijms18071350Sun JW, Qiu S, Yang JY, Chen X, Li HX. Hsa_circ_0124055 and hsa_circ_0101622 regulate proliferation and apoptosis in thyroid cancer and serve as prognostic and diagnostic indicators. Eur Rev Med Pharmacol Sci. 2020;24(8):4348-4360. DOI: 10.26355/eurrev_202004_21016Lupo M, Guttler R, Geck Z, Tonozzi TR, Kammesheidt A, Braunstein GD. Is measurement of circulating tumor dna of diagnostic use in patients with thyroid nodules? Endocr Pract. 2018;24(5):453-459. DOI: 10.4158/EP-2017-0213Lan X, Cao J, Xu J, Chen C, Zheng C, et al. Decreased expression of hsa_circ_0137287 predicts aggressive clinicopathologic characteristics in papillary thyroid carcinoma. J Clin Lab Anal. 2018;32(8):e22573. DOI: 10.1002/jcla.22573Cao S, Yu S, Yin Y, Su L, Hong S, et al. Genetic alterations in cfDNA of benign and malignant thyroid nodules based on amplicon-based next-generation sequencing. Ann Transl Med. 2020;8(19):1225. DOI: 10.21037/atm-20-4544Wu G, Zhou W, Pan X, Sun Z, Sun Y, et al. Circular RNA Profi ling Reveals Exosomal circ_0006156 as a Novel Biomarker in Papillary Th yroid Cancer. Mol Th er Nucleic Acids. 2020;19:1134-1144. DOI: 10.1016/j.omtn.2019.12.025Suh YJ, Kwon MJ, Noh HM, Lee HK, Ra YJ, Kim NY. Limited Clinical and Diagnostic Utility of Circulating Tumor DNA Detection in Patients with Early-Stage Well-Diff erentiated Th yroid Cancer: Comparison with Benign Th yroid Nodules and Healthy Individuals. Healthcare (Basel). 2021;9(4):386. DOI: 10.3390/healthcare9040386Salvianti F, Giuliani C, Petrone L, Mancini I, Vezzosi V, et al. Integrity and Quantity of Total Cell-Free DNA in the Diagnosis of Th yroid Cancer: Correlation with Cytological Classifi cation. Int J Mol Sci. 2017;18(7):1350. DOI: 10.3390/ijms18071350Wahl RL, Chareonthaitawee P, Clarke B, Drzezga A, Lindenberg L, et al. Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Th erapy. J Nucl Med. 2021;62(1):6-14. DOI: 10.2967/jnumed.120.253450Lupo M, Guttler R, Geck Z, Tonozzi TR, Kammesheidt A, Braunstein GD. Is measurement of circulating tumor dna of diagnostic use in patients with thyroid nodules? Endocr Pract. 2018;24(5):453-459. DOI: 10.4158/EP-2017-0213Nagarajah J, Janssen M, Hetkamp P, Jentzen W. Iodine Symporter Targeting with 124I/131I Th eranostics. J Nucl Med. 2017;58(Suppl 2):34S-38S. DOI: 10.2967/jnumed.116.186866Cao S, Yu S, Yin Y, Su L, Hong S, et al. Genetic alterations in cfDNA of benign and malignant thyroid nodules based on amplicon-based next-generation sequencing. Ann Transl Med. 2020;8(19):1225. DOI: 10.21037/atm-20-4544Wu D, Ylli D, Heimlich SL, Burman KD, Wartofsky L, Van Nostrand D. 124I Positron Emission Tomography/Computed Tomography Versus Conventional Radioiodine Imaging in Diff erentiated Th yroid Cancer: A Review. Th yroid. 2019;29(11):1523-1535. DOI: 10.1089/thy.2018.0598Suh YJ, Kwon MJ, Noh HM, Lee HK, Ra YJ, Kim NY. Limited Clinical and Diagnostic Utility of Circulating Tumor DNA Detection in Patients with Early-Stage Well-Diff erentiated Th yroid Cancer: Comparison with Benign Th yroid Nodules and Healthy Individuals. Healthcare (Basel). 2021;9(4):386. DOI: 10.3390/healthcare9040386Jin Y, Van Nostrand D, Cheng L, Liu M, Chen L. Radioiodine refractory diff erentiated thyroid cancer. Crit Rev Oncol Hematol. 2018;125:111-120. DOI: 10.1016/j.critrevonc.2018.03.012Wahl RL, Chareonthaitawee P, Clarke B, Drzezga A, Lindenberg L, et al. Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Th erapy. J Nucl Med. 2021;62(1):6-14. DOI: 10.2967/jnumed.120.253450Treglia G, Caldarella C, Saggiorato E, Ceriani L, Orlandi F, et al. Diagnostic performance of (99m)Tc-MIBI scan in predicting the malignancy of thyroid nodules: a metaanalysis. Endocrine. 2013;44(1):70-8. DOI: 10.1007/s12020-013-9932-zNagarajah J, Janssen M, Hetkamp P, Jentzen W. Iodine Symporter Targeting with 124I/131I Th eranostics. J Nucl Med. 2017;58(Suppl 2):34S-38S. DOI: 10.2967/jnumed.116.186866Yordanova A, Mahjoob S, Lingohr P, Kalff J, Türler A, et al. Diagnostic accuracy of [99mTc]Tc-Sestamibi in the assessment of thyroid nodules. Oncotarget. 2017;8(55):94681-94691. DOI: 10.18632/oncotarget.21866Wu D, Ylli D, Heimlich SL, Burman KD, Wartofsky L, Van Nostrand D. 124I Positron Emission Tomography/Computed Tomography Versus Conventional Radioiodine Imaging in Diff erentiated Th yroid Cancer: A Review. Th yroid. 2019;29(11):1523-1535. DOI: 10.1089/thy.2018.0598Campennì A, Siracusa M, Ruggeri RM, Laudicella R, Pignata SA, et al. Diff erentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: a new quantitative method for improving diagnostic accuracy. Sci Rep. 2017;7(1):6147. DOI: 10.1038/s41598-017-06603-3Jin Y, Van Nostrand D, Cheng L, Liu M, Chen L. Radioiodine refractory diff erentiated thyroid cancer. Crit Rev Oncol Hematol. 2018;125:111-120. DOI: 10.1016/j.critrevonc.2018.03.012Halicek M, Lu G, Little JV, Wang X, Patel M, et al. Deep convolutional neural networks for classifying head and neck cancer using hyperspectral imaging. J Biomed Opt. 2017;22(6):60503. DOI: 10.1117/1.JBO.22.6.060503.Treglia G, Caldarella C, Saggiorato E, Ceriani L, Orlandi F, et al. Diagnostic performance of (99m)Tc-MIBI scan in predicting the malignancy of thyroid nodules: a meta-analysis. Endocrine. 2013;44(1):70-8. DOI: 10.1007/s12020-013-9932-zYordanova A, Mahjoob S, Lingohr P, Kalff J, Türler A, et al. Diagnostic accuracy of [99mTc]Tc-Sestamibi in the assessment of thyroid nodules. Oncotarget. 2017;8(55):94681-94691. DOI: 10.18632/oncotarget.21866Yordanova A, Mahjoob S, Lingohr P, Kalff J, Türler A, et al. Diagnostic accuracy of [99mTc]Tc-Sestamibi in the assessment of thyroid nodules. Oncotarget. 2017;8(55):94681-94691. DOI: 10.18632/oncotarget.21866Campennì A, Siracusa M, Ruggeri RM, Laudicella R, Pignata SA, et al. Diff erentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: a new quantitative method for improving diagnostic accuracy. Sci Rep. 2017;7(1):6147. DOI: 10.1038/s41598-017-06603-3Campennì A, Siracusa M, Ruggeri RM, Laudicella R, Pignata SA, et al. Diff erentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: a new quantitative method for improving diagnostic accuracy. Sci Rep. 2017;7(1):6147. DOI: 10.1038/s41598-017-06603-3Halicek M, Lu G, Little JV, Wang X, Patel M, et al. Deep convolutional neural networks for classifying head and neck cancer using hyperspectral imaging. J Biomed Opt. 2017;22(6):60503. DOI: 10.1117/1.JBO.22.6.060503.Halicek M, Lu G, Little JV, Wang X, Patel M, et al. Deep convolutional neural networks for classifying head and neck cancer using hyperspectral imaging. J Biomed Opt. 2017;22(6):60503. DOI: 10.1117/1.JBO.22.6.060503.

The authors declare that there are no conflicts of interest present.